At a Glance
| Alpha-GPC | Aniracetam | |
|---|---|---|
| Class | Nootropic | Nootropic |
| Common Dose (oral) | 300–500 mg | 1200–1800 mg |
| Total Duration | 2.2–5.3 hrs | 1.8–4 hrs |
| Routes | oral | oral |
| Effects | 16 documented | 21 documented |
Alpha-GPC, a Nootropic, and Aniracetam, a Nootropic, are frequently compared by users looking to understand their relative effects, dosage profiles, and safety considerations. Both are classified as Nootropics, meaning they share a common pharmacological foundation. They share 9 documented effects in common, with 7 effects unique to Alpha-GPC and 12 unique to Aniracetam. This side-by-side comparison covers dosage, duration, subjective effects, and safety to help you make informed decisions.
| Alpha-GPC | Aniracetam | |
|---|---|---|
| Class | Nootropic | Nootropic |
| Common Dose (oral) | 300–500 mg | 1200–1800 mg |
| Total Duration | 2.2–5.3 hrs | 1.8–4 hrs |
| Routes | oral | oral |
| Effects | 16 documented | 21 documented |
| Level | Alpha-GPC | Aniracetam |
|---|---|---|
| Threshold | 50 mg | 350 mg |
| Light | 100–300 mg | 500–1200 mg |
| Common | 300–500 mg | 1200–1800 mg |
| Strong | 500–1000 mg | 1800–2400 mg |
| Heavy | 1000 mg | 2400 mg |
Alpha-GPC
Aniracetam
No direct interaction data available between these substances. This does not mean the combination is safe.
No dangerous interactions recorded.
No dangerous interactions recorded.